- API
Any substance that is represented for use in a drug and that, when used in the manufacturing, processing, or packaging ...
- Active Ingredient
Any component that is intended to furnish pharmacological activity or other direct effect in the diagnosis, cure, ...
- CAS No.
Unique number assigned to a specific chemical (identified by its chemical name) by the American Chemical Society and ...
Astragaloside IV
Catalog No. | PI0021 |
---|---|
CAS No. | 84687-43-4 |
Molecular Formula | C41H68O14 |
Molecular Weight | 784.97 |
Purity | 5%-98% HPLC |
Package | 25 kg/drum |
Appearance | Powder |
Shelf Life | 2 years |
Note: This astragaloside iv can also be used as reference standards. You can find it under the category of Reference Substance at Herbalext.com. |
Safety Tips of Astragaloside IV
Handling of astragaloside iv should only be performed by personnel trained and familiar with handling of potent active pharmaceutical ingredients. Moderate to severe irritant to the skin and eyes.
Related Products
-
Catalog No.: HE0024
Specification: 30% 60% glucan UV
Package: 25 kg/drum
Botanical Source: Avena Sativa (Oat)
Related Applications
Liver Protection
The liver is the primary organ responsible for expelling and breaking down toxins entering the body. In particular, it produces bile, a detoxifying agent metabolically indispensable in breaking down fats from food. Many chemicals from nature could protect liver to help the process of detoxication.Anti-fatigue
Anti-fatigue medicines are immunity regulators that can resist caducity and fatigue, reduce blood sugar, enhance memory, activate skin cells, enhance the skin elasticity, reduce furrow etc.
Related Researches
- 1. Xiang-Qi-Tang and its active components exhibit anti-inflammatory and anticoagulant properties by inhibiting MAPK and NF-κB signaling pathways in LPS-treated rat cardiac microvascular endothelial cells.
He CL, et al. Immunopharmacol Immunotoxicol 2013 Apr;35(2):215-24.
- 2. Astragaloside IV inhibited the activity of CYP1A2 in liver microsomes and influenced theophylline pharmacokinetics in rats.
Zhang YH, et al. J Pharm Pharmacol 2013 Jan;65(1):149-55.
- 3. Astragaloside IV prevents acute kidney injury in two rodent models by inhibiting oxidative stress and apoptosis pathways.
Gui D, et al. Apoptosis 2013 Apr;18(4):409-22.
- 4. Astragaloside IV ameliorates renal injury in streptozotocin-induced diabetic rats through inhibiting NF-κB-mediated inflammatory genes expression.
Gui D, et al. Cytokine 2013 Mar;61(3):970-7.
- 5. Astragaloside IV suppresses collagen production of activated hepatic stellate cells via oxidative stress-mediated p38 MAPK pathway.
Li X, et al. Free Radic Biol Med 2013 Mar 1;60C:168-176.
- 6. Astragaloside IV-loaded nanoparticle-enriched hydrogel induces wound healing and anti-scar activity through topical delivery.
Chen X, et al. Int J Pharm 2013 Apr 15;447(1-2):171-81.
- 7. Anti-inflammatory cycloartane-type saponins of Astragalus membranaceus.
Lee DY, et al. Molecules 2013 Mar 25;18(4):3725-32.
- 8. Effects of Astragaloside IV on Action Potentials and Ionic Currents in Guinea-Pig Ventricular Myocytes.
Zhao M, et al. Biol Pharm Bull 2013;36(4):515-21.
- 9. Genetic and Pharmacological Inhibition of Rheb1-mTORC1 Signaling Exerts Cardioprotection against Adverse Cardiac Remodeling in Mice.
Wu X, et al. Am J Pathol 2013 Apr 6.
- 10. Simultaneous quantification of paeoniflorin, nobiletin, tangeretin, liquiritigenin, isoliquiritigenin, liquiritin and formononetin from Si-Ni-San extract in rat plasma and tissues by liquid chromatography-tandem mass spectrometry.
Li T, et al. Biomed Chromatogr 2013 Apr 11.